oxazolidin-2-one has been researched along with Preterm Birth in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bauer, K; Groll, AH; Hoehn, R; Schaefer, V; Schloesser, RL | 1 |
Hammerschlag, MR; Kohlhoff, S; Kumar, S; Sharma, R; Valencia, G | 1 |
2 other study(ies) available for oxazolidin-2-one and Preterm Birth
Article | Year |
---|---|
Linezolid treatment of glycopeptide-resistant Enterococcus faecium in very low birth weight premature neonates.
Topics: Acetamides; Drug Resistance, Bacterial; Enterococcus faecium; Female; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Linezolid; Male; Oxazolidinones; Premature Birth; Safety | 2006 |
Treatment of vancomycin-resistant Enterococcus faecium ventriculitis in a neonate.
Topics: Acetamides; Anti-Infective Agents; Enterococcus faecium; Female; Humans; Infant, Newborn; Linezolid; Meningitis, Bacterial; Microbial Sensitivity Tests; Oxazolidinones; Premature Birth; Treatment Outcome; Vancomycin Resistance; Ventriculoperitoneal Shunt | 2007 |